KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Construction in Progress (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Construction in Progress for 11 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Construction in Progress rose 6.16% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 6.16% increase, with the full-year FY2025 number at $1.6 billion, up 6.16% from a year prior.
  • Construction in Progress was $1.6 billion for Q4 2025 at Bristol Myers Squibb, up from $1.5 billion in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $1.8 billion in Q2 2025 to a low of $519.0 million in Q1 2021.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 define the central range for Construction in Progress.
  • Peak YoY movement for Construction in Progress: soared 69.93% in 2021, then increased 2.09% in 2023.
  • Bristol Myers Squibb's Construction in Progress stood at $764.0 million in 2021, then soared by 37.83% to $1.1 billion in 2022, then increased by 2.09% to $1.1 billion in 2023, then surged by 41.86% to $1.5 billion in 2024, then increased by 6.16% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Construction in Progress are $1.6 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.8 billion (Q2 2025).